NORGES BANK, a registered investment adviser, initiated a new position in Gilead Sciences, Inc. (NASDAQ:GILD) during Q4 2025, according to its most recent 13F filing with the…
NORGES BANK, a registered investment adviser, initiated a new position in Gilead Sciences, Inc. (NASDAQ:GILD) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 21,322,732 shares of the Healthcare company, valued at approximately $2.6B as of the filing date.
Gilead Sciences, Inc.'s stock currently trades at $151.02 with a market capitalization of $152.9B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · GILD
$150.11
Down: -$0.78 · -0.52%
Live quote updated
Keep reading
institutional ·
institutional ·
analyst ·
analyst ·
